CBS leverage software intelligence, combining with clinical knowledge, to quickly and easily optimize the clinical trial conduction and reporting, no matter how complex it is, to ensure strong and effective communication improve across the teams involved in the study at company level, at site level and at sponsor level.
CBS has extensive experience working with CROs, vendors and study teams to support clinical, safety and marketing programs. These partnerships allow CBS to support a full service CRO approach. This includes employees with experience across many therapeutic areas, and across Phase I, Phase II/III and Phase IV/ Post-marketing studies. If data from multiple studies and / or within a program are available, our visualization technology can help make access to this data easier.
Non-Interventional studies (NIS) are the core source of clinical information for vast number of patients’ populations and important element in the integration of clinical development. Non Interventional studies cover the following categories:
- Patient Registry
- Disease Registry
- Post-Marketing Surveillance studies
- Epidemiological studies
- case control studies
- cohort studies
- Post Authorization Safety studies (PASS)
- Investigator Initiated Trials (IIT)
- Pharmacoeconomic studies
- Observational studies
Interventional Studies (PhaseI-IV) :
With the completion of a significant number of projects, covering a broad range of therapeutic areas, we offer a portfolio of proven experience in Interventional Studies. Our well trained professionals are readily available to meet project needs and provide solutions, advice and local expertise.